Ionis Pharmaceuticals, Inc. (IONS)
81.66
+1.36
(+1.70%)
USD |
NASDAQ |
Jan 12, 16:00
82.00
+0.34
(+0.41%)
After-Hours: 18:04
Ionis Pharmaceuticals Research and Development Expense (Quarterly): 217.13M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.466B |
| Merck & Co., Inc. | 3.552B |
| Pfizer Inc. | 2.492B |
| Cogent Biosciences, Inc. | 67.84M |
| Twist Bioscience Corp. | 17.01M |